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Abstract Sphingolipid metabolites, such as sphingosine and
ceramide, are known to play important roles in cell proliferation,
differentiation and apoptosis, but the physiological roles of
phytosphingosine (PHS) and phytoceramide (PHC) are poorly
understood. In this study we investigated the effects of PHS, C2-
PHC (N-acetylPHS) and C6-PHC (N-hexanoylPHS) on cell
growth and intracellular signalling enzymes. Treatment of
Chinese hamster ovary (CHO) cells with PHS, C2-PHC or
C6-PHC resulted in cell death in a time- and dose-dependent
manner. C2-PHC induced internucleosomal DNA fragmenta-
tion, whereas PHS or C6-PHC had little if any effect on DNA
fragmentation under the same experimental conditions. Both
PHS and C2-PHC inhibited carbachol-induced activation of
phospholipase D (PLD), but not of phospholipase C (PLC), in
CHO cells expressing the Caenorhabditis elegans muscarinic
acetylcholine receptor (mAChR). On the other hand, no
significant effect of C6-PHC on PLD or PLC was observed.
Our results show that PHS and C2-PHC exert strong cytotoxic
effects on CHO cells and modulate the mAChR-mediated signal
transduction pathway. ß 2001 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Accumulating evidence indicates that sphingolipid metabo-
lites, such as ceramide and sphingosine, serve as mediators of
a variety of biological functions including the regulation of
cell growth [1]. Ceramide, the basic building block of sphin-
golipids, has been a material of main interest. In response to
cytokines, hormones, antigens, DNA-damaging agents, and
many other chemicals, ceramide is generated from the hydro-
lysis of sphingomyelin by sphingomyelinase [2^4]. Ceramide
has been postulated as an intracellular signalling molecule to
modulate cell di¡erentiation, apoptosis, protein secretion, and
in£ammatory responses [5].
Phospholipase D (PLD) plays an important role in signal
transduction by catalyzing the hydrolysis of phosphatidylcho-
line to generate phosphatidic acid and choline in response to
neurotransmitters, hormones, cytokines, and growth factors
[6]. Phosphatidic acid can be dephosphorylated to diacylgly-
cerol, which is an activator of certain isoforms of protein ki-
nase C [7]. Like phospholipase C (PLC), which hydrolyzes
phosphatidylinositol 4,5-bisphosphate to inositol 1,4,5-tris-
phosphate and diacylglycerol, PLD is known to participate
in diverse cellular functions. PLD has been implicated in sen-
escence, di¡erentiation, and apoptosis [8^10]. Sphingolipid
metabolites have been shown to regulate PLD activity in
many cell types [11^15], indicating crosstalk between sphingo-
lipid and glycerophospholipid metabolic pathways.
Recently, we have cloned a muscarinic acetylcholine recep-
tor (mAChR), termed GAR-3, from Caenorhabditis elegans
[16]. Ligand binding speci¢city and e¡ector coupling e⁄cacy
of the C. elegans mAChR are generally similar to those of
mammalian counterparts [16], suggesting the evolutionary
conservation of the receptor. More recently, we have shown
that in Chinese hamster ovary (CHO) cells expressing the C.
elegans mAChR, carbachol induces the activation of PLD,
and that PLC, protein kinase C, Ca2/calmodulin-dependent
kinase II and protein tyrosine kinase are involved in the PLD
activation [17].
Phytosphingosine (PHS) and phytoceramide (PHC) are
abundant in fungi and plants [18], and also found in animals
including humans [19]. PHS and PHC are structurally similar
to sphingosine and ceramide, respectively, with one major
di¡erence: PHS and PHC possess a hydroxyl group at C-4
of the sphingoid long-chain base while sphingosine and cer-
amide have a trans double bond between C-4 and C-5. In
contrast to sphingosine and ceramide, the roles for PHS and
PHC in cellular functions are unclear although recent experi-
ments showed that PHS and PHC are involved in the heat
stress response of the yeast Saccharomyces cerevisiae [20^22].
In the current work, we investigated the e¡ects of PHS, C2-
PHC (N-acetylPHS) and C6-PHC (N-hexanoylPHS) on the
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regulation of cell growth and intracellular signalling enzymes,
namely PLC and PLD, in CHO cells.
2. Materials and methods
2.1. Materials
PHS, C2-PHC and sphingosine were obtained from Doosan Bio-
tech, and C2-ceramide was from Tocris. C6-PHC was synthesized by
coupling PHS with hexanoic acid. The identity of C6-PHC was con-
¢rmed by nuclear magnetic resonance spectroscopy and matrix-assist-
ed laser desorption ionization-time of £ight mass spectrometry. The
purity of the C6-PHC was s 98% by high performance liquid chro-
matography. Carbamylcholine chloride (carbachol) was purchased
from Sigma. Culture medium and fetal bovine serum (FBS) were
from Gibco.
2.2. Cell culture and cell viability test
CHO-K1 cells were grown in Dulbecco’s modi¢ed Eagle’s medium
containing 10% FBS at 5% CO2. To measure cell viability, the trypan
blue exclusion method was used. Cells were cultured in 24-well plates
with serum-free medium for 5 h and treated with various sphingolip-
ids (solubilized in ethanol). Trypan blue solution (0.4%, Sigma) was
added and viable cells were counted under a microscope (Olympus
IMT-2).
2.3. Assay for DNA fragmentation
CHO cells were cultured in 24-well plates with serum-free medium
for 5 h and further incubated in the presence of various sphingolipids.
DNA was prepared using DNAzol (Molecular Research Center) and
analyzed by electrophoresis on a 2% agarose gel.
2.4. PLD activity assay
The GAR-3/CHO cells stably expressing the C. elegans mAChR
[16] were labeled overnight with 1 WCi/ml [3H]myristic acid (NEN).
The cells were washed and preincubated in HEPES bu¡er containing
various sphingolipids for 20 min. After incubation in HEPES bu¡er
containing 0.3% 1-butanol for 10 min, the cells were stimulated with
1 mM carbachol for 20 min. The reaction was terminated by remov-
ing the medium, washing on ice with 5 ml of ice-cold phosphate-bu¡-
ered saline (PBS), and adding 1.5 ml of ice-cold methanol. The cell
harvest, lipid extraction, and determination of [3H]phosphatidyl-
butanol (PtdBut) production were performed as described [17].
2.5. PLC activity assay
GAR-3/CHO cells were seeded in six-well plates at 5U105 cells per
well and cultured for 1 day. The cells were labeled overnight with
1 WCi/ml of myo-[2-3H]inositol (Amersham). The cells were washed
twice with PBS and incubated with PBS containing 10 mM LiCl
(PBS-Li) for 15 min. The cells were preincubated with various sphin-
golipids for 20 min and treated with 1 ml of fresh PBS-Li containing
1 mM carbachol for 20 min. The cell harvest and measurement of
[3H]inositol phosphates (IPs) formation were performed as described
[16].
3. Results
3.1. PHS, C2-PHC and C6-PHC exert lethal e¡ects in CHO
cells
To investigate the physiological roles of PHS, C2-PHC and
C6-PHC, we ¢rst examined the e¡ects of these sphingolipids
on cell viability. All of these sphingolipids led to a time-de-
pendent (Fig. 1A) and dose-dependent (Fig. 1B) death of
CHO cells. PHS displayed a cytotoxic e¡ect comparable to
that of sphingosine. By contrast, C2-PHC showed a much
stronger cytotoxic e¡ect than C2-ceramide, implying that the
hydroxyl group at C-4 of the sphingoid long-chain base is
critical for the antiproliferative activity. The cytotoxic e¡ect
of C6-PHC, however, was signi¢cantly weaker than that of
C2-PHC. This di¡erence suggests that the size of the N-acyl
group is also important for the cytotoxicity. In control experi-
ments, ethanol (0.1%) treatment did not show any signi¢cant
cytotoxic e¡ect (Fig. 1A). Taken together, these results sug-
gest the possibility that PHS, C2-PHC and C6-PHC, as well
as sphingosine and C2-ceramide, act as mediators of cell death
in CHO cells.
3.2. C2-PHC induces internucleosomal DNA fragmentation
We next examined whether PHS, C2-PHC or C6-PHC in-
duces DNA fragmentation in CHO cells. C2-PHC (20 WM)
elicited DNA fragmentation after 3 h of treatment, whereas
neither PHS nor C6-PHC induced DNA fragmentation under
the same experimental conditions (Fig. 2A). No DNA frag-
mentation was observed by sphingosine or C2-ceramide treat-
Fig. 1. PHS, C2-PHC and C6-PHC induce cell death. (A) CHO
cells were grown in a serum-free medium for 5 h and treated with
20 WM of PHS (closed triangles), C2-PHC (closed circles), C6-PHC
(closed squares), sphingosine (open triangles), C2-ceramide (open
circles), or ethanol (diamonds) for the indicated times. (B) CHO
cells were grown in a serum-free medium for 5 h and treated with
various concentrations of PHS (closed triangles), C2-PHC (closed
circles), C6-PHC (closed squares), sphingosine (open triangles), or
C2-ceramide (open circles) for 3 h. Cells were then stained with try-
pan blue and the viable cells were counted. The data are mean þ
S.E.M. values of triplicate determinations. Similar results were ob-
tained from three separate experiments.
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ment (Fig. 2A). We were unable to observe any signi¢cant
level of DNA fragmentation even after 12 h incubation with
PHS, C6-PHC, sphingosine, or C2-ceramide (data not
shown). The di¡erential e¡ects of C2-PHC and C6-PHC on
DNA fragmentation may indicate that the mechanisms by
which these two sphingolipids induce cell death are distinct.
The e¡ect of C2-PHC on DNA fragmentation was time-
dependent (Fig. 2B). Internucleosomal DNA fragmentation
was barely detectable after 1 h treatment of 20 WM C2-
PHC, but was evident after 2 h treatment. After 3 h treat-
ment, the DNA degradation was even greater. We also ob-
served that C2-PHC induced internucleosomal DNA fragmen-
tation in a dose-dependent fashion (Fig. 2C). After 3 h
incubation, a very low level of DNA degradation was detect-
able in the presence of 5 WM or 10 WM PHC. In the presence
of 20 WM or 30 WM C2-PHC, the internucleosomal DNA
fragmentation pattern became distinct.
3.3. PHS and C2-PHC reduce PLD activation, but not PLC
activation, mediated by mAChRs
PLD is considered to be a critical cell growth-regulating
enzyme whose activity is controlled by many sphingolipids
[6,8]. We thus asked whether PHS, C2-PHC or C6-PHC af-
fects agonist-induced activation of PLD. For this purpose, we
used the CHO cells stably expressing GAR-3, the C. elegans
mAChR (GAR-3/CHO) [16]. GAR-3/CHO cells have been
shown to possess an endogenous PLD enzyme (PLD1) and
to activate the PLD by treatment with carbachol, a muscarinic
agonist [17]. PHS and C2-PHC greatly inhibited the PLD
activity stimulated by the C. elegans mAChR, while C6-
PHC had little, if any, e¡ect on the mAChR-stimulated
PLD activity (Fig. 3A). The inhibitory e¡ects of sphingosine
Fig. 2. C2-PHC induces internucleosomal DNA fragmentation. (A)
CHO cells were grown in a serum-free medium for 5 h and treated
with various sphingolipids (20 WM each) for 3 h. DNA was isolated
and analyzed by electrophoresis on a 2% agarose gel. Control sam-
ple was treated with 0.1% ethanol (EtOH). (B) CHO cells were
treated with C2-PHC (20 WM) for the indicated times and the time-
dependent DNA fragmentation pattern was analyzed by agarose gel
electrophoresis. Lambda DNA digested with HindIII and EcoRI
was used as the molecular weight marker (M). E, EtOH. (C) CHO
cells were treated with various concentrations of C2-PHC for 3 h
and the dose-dependent DNA fragmentation pattern was analyzed
by agarose gel electrophoresis. E, EtOH.
Fig. 3. PHS and C2-PHC inhibit mAChR-mediated PLD activation.
(A) GAR-3/CHO cells were serum-deprived and labeled with
[3H]myristic acid. The cells were pretreated with various sphingolip-
ids (10 WM each) for 20 min and 0.3% 1-butanol for 10 min. Fol-
lowing incubation with 1 mM carbachol for 20 min, lipids were ex-
tracted and the production of [3H]PtdBut was analyzed. The
production of [3H]PtdBut with ethanol (EtOH) treatment was set to
be 100%. (B) Dose-dependent inhibition of carbachol-induced PLD
activation by PHS (triangles) and C2-PHC (circles). The data are
mean þ S.E.M. values from three separate experiments, each per-
formed in duplicate.
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and C2-ceramide were similar to those of PHS and C2-PHC
(Fig. 3A).
The inhibition of carbachol-stimulated PLD activity by
PHS and C2-PHC was dose-dependent (Fig. 3B). The inhibi-
tion appeared to be incomplete (57^65% inhibition), suggest-
ing that both sphingolipid-sensitive and -insensitive pathways
for the PLD activation may exist in CHO cells.
In GAR-3/CHO cells, carbachol activates PLC [16,17] and
this PLC activation is a prerequisite for the activation of PLD
[17]. We examined whether PHS or C2-PHC inhibits mAChR-
mediated PLC activation. Neither PHS nor C2-PHC signi¢-
cantly altered the PLC activity stimulated by carbachol (Fig.
4). C6-PHC had little e¡ect on the PLC activity as well.
4. Discussion
Extensive evidence suggests that sphingosine and ceramide
are critical regulators of cell proliferation and apoptosis [1,2] ;
however, the roles of PHS and PHC in cellular functions are
poorly characterized. In the current work, we found that PHS
and C2-PHC exert lethal e¡ects in CHO cells and inhibit
mAChR-stimulated PLD activation. Our ¢ndings suggest
that PHS and C2-PHC might regulate cell growth and the
agonist-induced signal transduction pathway in mammalian
cells.
Sphingolipid metabolites control cell growth presumably by
altering enzyme activities involved in signal transduction. In
particular, reduction in PLD activity has been postulated to
be responsible for cell death caused by ceramide treatment
[23,24]. In agreement with this postulation, our results showed
that PHS and C2-PHC, as well as sphingosine and C2-ceram-
ide, suppress receptor-stimulated PLD activity in the same
concentration range that induces cell death. However, C6-
PHC, which exhibited a strong cytotoxic e¡ect (Fig. 1), did
not signi¢cantly alter the receptor-stimulated PLD activity
(Fig. 3). In fact, some controversy exists about the relation-
ship between PLD and mitogenesis [25,26]. Further study is
required to de¢ne the role of PLD in the regulation of cell
growth.
Treatment of GAR-3/CHO cells with carbachol activates
PLC and PLD [16,17]. The speci¢c PLC inhibitor, U73122,
almost completely blocks the PLD activation [17], suggesting
that PLC is the upstream signal for the PLD activation. In
this study, PHS and C2-PHC were shown to inhibit the car-
bachol-stimulated PLD activation (Fig. 3) without a¡ecting
the PLC activation (Fig. 4), providing evidence that both
sphingolipids interfere with the mAChR-mediated signal
transduction pathway downstream from PLC and upstream
of PLD. It is possible that PHS and C2-PHC act on protein
kinase C, protein tyrosine kinase, or Ca2/calmodulin-depen-
dent kinase II, since these protein kinases have been postu-
lated to be involved in the PLC-dependent activation of PLD
in GAR-3/CHO cells [17]. All these kinases have been shown
to be regulated by ceramide and sphingosine [2]. Alternatively,
PLD itself could be the direct target of the sphingolipids.
Our data suggest that the three PHS-based sphingolipids
examined in this study (PHS, C2-PHC and C6-PHC) a¡ect
cellular functions via distinct mechanisms. Although all three
sphingolipids exerted cytotoxic e¡ects (Fig. 1), only C2-PHC
e¡ectively evoked internucleosomal DNA fragmentation (Fig.
2). While PHS and C2-PHC substantially inhibited mAChR-
mediated PLD activation, C6-PHC had little e¡ect on the
enzyme activity (Fig. 4). Taken together, it seems likely that
the three sphingolipids perform di¡erent roles in cell signal-
ling.
In the current study we used PHCs with short acyl chains
(C2 and C6), which are supposed to be cell-permeable. Inter-
estingly, these two short-chain PHCs exhibited distinct cellu-
lar activities. Presumably CHO cells have the ability to recog-
nize the length of the acyl chain in the PHC. It will be of
interest to compare the cellular functions of PHCs with di¡er-
ent acyl chain lengths, including C16-PHC and C18-PHC.
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